For HCC, although there is currently no research evidence supporting the role of CLEC4G, the study by Zhang et al. has mentioned that CLEC4S, a member of the CLEC4G family, is a therapeutic target in the immune microenvironment of HCC [18]. This evidence concerns the gene CLEC4G and hepatocellular carcinoma.